Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3977630 | Brachytherapy | 2009 | 6 Pages |
Abstract
Early clinical experience with the SAVI demonstrates the ease of placement of a single-entry brachytherapy device combined with the increased dose modulation of interstitial brachytherapy. Dose to normal structures has remained exceedingly low. Almost half of evaluated patients were not candidates for other single-entry brachytherapy devices because of skin spacing or breast size, demonstrating an expansion of candidates for single-entry partial breast brachytherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Catheryn M. Yashar, Sarah Blair, Anne Wallace, Dan Scanderbeg,